The invention relates to an anti-RhD monoclonal antibody that consists of a tetrameric immunoglobulin IgGI with two heavy chains and two light chains, the heavy chain including the amino acid sequence SEQ ID N°2 with a phenylalanine residue at position 68, and the light chain including the amino acid sequence SEQ ID N°4.